Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Gilead Sciences Inc (GILD)

Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 105,386,704
  • Shares Outstanding, K 1,245,853
  • Annual Sales, $ 27,116 M
  • Annual Income, $ 5,665 M
  • 60-Month Beta 0.18
  • Price/Sales 3.86
  • Price/Cash Flow 9.47
  • Price/Book 5.80
Trade GILD with:

Options Overview Details

View History
  • Implied Volatility 24.12% ( +1.60%)
  • Historical Volatility 15.46%
  • IV Percentile 67%
  • IV Rank 43.82%
  • IV High 33.98% on 08/05/24
  • IV Low 16.44% on 12/05/23
  • Put/Call Vol Ratio 0.97
  • Today's Volume 6,726
  • Volume Avg (30-Day) 18,277
  • Put/Call OI Ratio 0.84
  • Today's Open Interest 251,766
  • Open Int (30-Day) 242,557

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 26 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 1.66
  • Number of Estimates 12
  • High Estimate 1.95
  • Low Estimate 1.45
  • Prior Year 2.29
  • Growth Rate Est. (year over year) -27.51%

Price Performance

See More
Period Period Low Period High Performance
1-Month
77.74 +8.81%
on 09/05/24
85.43 -0.98%
on 10/02/24
+5.46 (+6.90%)
since 09/04/24
3-Month
66.01 +28.15%
on 07/05/24
85.43 -0.98%
on 10/02/24
+18.00 (+27.03%)
since 07/03/24
52-Week
62.07 +36.28%
on 05/31/24
87.86 -3.73%
on 01/19/24
+9.85 (+13.18%)
since 10/04/23

Most Recent Stories

More News
AZN Stock Slips as Dato-DXd Cancer Study Misses Survival Goal

AstraZeneca AZN and Japanese partner Daiichi Sankyo announced that their antibody-drug conjugate, datopotamab deruxtecan (Dato-DXd), failed to achieve statistical significance in the final overall survival...

AZN : 77.47 (-0.59%)
MRK : 109.77 (-0.37%)
GILD : 84.59 (+0.50%)
PFE : 28.58 (+0.85%)
Biotech Boom Ahead? Key Stocks and ETFs to Watch Now

The Federal Reserve's recent 50bps rate cut could significantly boost biotech companies by lowering borrowing costs and improving access to capital.

IBB : 143.90 (+0.90%)
GILD : 84.59 (+0.50%)
XBI : 97.51 (+0.90%)
3 Dirt Cheap Stocks to Buy Right Now

Bargain hunters should love these great stocks.

CRSP : 45.37 (+1.05%)
GILD : 84.59 (+0.50%)
PFE : 28.58 (+0.85%)
Is Biogen Stock Underperforming the Dow?

Biogen has underperformed the Dow over the past year, but analysts are moderately optimistic about the stock’s prospects.

$DOWI : 42,352.75 (+0.81%)
GILD : 84.59 (+0.50%)
BIIB : 185.68 (+0.49%)
Got $200? 2 Healthcare Stocks to Buy and Hold Forever

These two stocks have had their issues in recent years, but both look like reliable long-term bets.

BMY : 53.96 (+0.67%)
GILD : 84.59 (+0.50%)
Why Gilead Sciences Stock Thrashed the Market Today

In drug development, solid performance in large-scale clinical trials is crucial.

GILD : 84.59 (+0.50%)
Stocks Finish Higher on Economic Optimism

The S&P 500 Index ($SPX ) (SPY ) Thursday closed up by +0.75%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up by +0.58%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up by +0.97%. Stocks...

$SPX : 5,751.07 (+0.90%)
SPY : 572.98 (+0.91%)
$DOWI : 42,352.75 (+0.81%)
DIA : 423.41 (+0.82%)
$IUXX : 20,035.02 (+1.22%)
QQQ : 487.32 (+1.19%)
ZNZ24 : 112-270s (-0.93%)
MU : 102.25 (+0.42%)
TXN : 202.71 (+0.52%)
INTC : 22.59 (+1.48%)
GFS : 39.65 (+1.80%)
NXPI : 234.24 (+0.43%)
Stocks Recover Early Losses on Supportive Corporate News

The S&P 500 Index ($SPX ) (SPY ) today is up by +0.20%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -0.08%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +0.42%. Stocks today recovered...

$SPX : 5,751.07 (+0.90%)
SPY : 572.98 (+0.91%)
$DOWI : 42,352.75 (+0.81%)
DIA : 423.41 (+0.82%)
$IUXX : 20,035.02 (+1.22%)
QQQ : 487.32 (+1.19%)
ZNZ24 : 112-270s (-0.93%)
MU : 102.25 (+0.42%)
NXPI : 234.24 (+0.43%)
TXN : 202.71 (+0.52%)
AMAT : 201.97 (+1.19%)
ON : 71.54 (+1.72%)
Stocks Fall Back as Weakness in Chip Stocks Drag the Market Lower

The S&P 500 Index ($SPX ) (SPY ) today is down by -0.18%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -0.35%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down by -0.12%. Stocks today are...

$SPX : 5,751.07 (+0.90%)
SPY : 572.98 (+0.91%)
$DOWI : 42,352.75 (+0.81%)
DIA : 423.41 (+0.82%)
$IUXX : 20,035.02 (+1.22%)
QQQ : 487.32 (+1.19%)
ZNZ24 : 112-270s (-0.93%)
MU : 102.25 (+0.42%)
NXPI : 234.24 (+0.43%)
AMAT : 201.97 (+1.19%)
ON : 71.54 (+1.72%)
KLAC : 787.39 (+1.66%)
Why Biotech ETFs Are Beating the Market

Biotech stocks have been outperforming the broader market over the past three months, driven by optimism regarding potential rate cuts. The Fed is expected to start cutting rates later this month, and...

REGN : 1,012.82 (-0.17%)
GILD : 84.59 (+0.50%)
IBB : 143.90 (+0.90%)
XBI : 97.51 (+0.90%)
SBIO : 37.67 (+1.89%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

See More Share

Business Summary

Gilead Sciences is a pioneer in developing drugs for the treatment of human immunodeficiency virus, liver diseases, hematology/oncology diseases and inflammation/respiratory diseases. The company has a strong HIV franchise with key HIV/AIDS therapies like tenofovir alafenamide based products - Genvoya,...

See More

Key Turning Points

3rd Resistance Point 86.02
2nd Resistance Point 85.49
1st Resistance Point 85.04
Last Price 84.59
1st Support Level 84.06
2nd Support Level 83.53
3rd Support Level 83.08

See More

52-Week High 87.86
Last Price 84.59
Fibonacci 61.8% 78.01
Fibonacci 50% 74.97
Fibonacci 38.2% 71.92
52-Week Low 62.07

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar